PortfoliosLab logo
iCAD, Inc. (ICAD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US44934S2068

CUSIP

44934S206

IPO Date

Dec 3, 1986

Highlights

Market Cap

$109.51M

EPS (TTM)

-$0.21

PEG Ratio

-0.56

Total Revenue (TTM)

$19.53M

Gross Profit (TTM)

$16.71M

EBITDA (TTM)

-$4.84M

Year Range

$1.18 - $4.02

Target Price

$3.75

Short %

1.19%

Short Ratio

0.20

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
ICAD vs. POWW ICAD vs. SPY
Popular comparisons:

Performance

Performance Chart


Loading data...

Returns By Period

iCAD, Inc. (ICAD) returned 118.03% year-to-date (YTD) and 128.00% over the past 12 months. Over the past 10 years, ICAD returned -2.10% annually, underperforming the S&P 500 benchmark at 10.89%.


ICAD

YTD

118.03%

1M

23.91%

6M

143.29%

1Y

128.00%

5Y*

-19.12%

10Y*

-2.10%

^GSPC (Benchmark)

YTD

1.30%

1M

12.79%

6M

1.49%

1Y

12.35%

5Y*

15.12%

10Y*

10.89%

*Annualized

Monthly Returns

The table below presents the monthly returns of ICAD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202574.86%-24.69%-14.52%66.02%16.67%118.03%
2024-23.73%32.59%-10.06%-11.18%1.40%-10.34%1.54%21.97%-2.80%18.85%-6.99%5.78%3.39%
202325.14%15.72%-53.21%16.94%-11.03%26.36%69.94%-17.69%-7.46%-36.49%20.15%9.94%-3.28%
2022-22.36%-13.60%-7.66%-19.28%6.11%4.71%-6.75%-19.30%-30.23%-9.05%-5.76%1.67%-74.58%
202115.08%21.72%14.76%-14.99%-8.81%5.23%-15.31%-17.74%-10.86%-1.86%-30.14%-2.31%-45.45%
20209.14%57.08%-44.89%55.59%2.80%-14.91%-7.71%17.46%-18.65%10.78%2.66%31.74%69.88%
201945.95%-5.00%0.78%0.58%20.00%2.08%0.00%-5.81%14.17%0.15%9.48%3.46%110.00%
2018-5.52%5.54%-10.20%23.70%-11.29%-9.76%-0.33%-1.32%-3.00%0.34%48.63%-14.75%7.56%
201715.30%0.80%27.93%16.22%-17.17%-9.50%-6.92%1.54%11.62%7.24%-24.26%-4.18%6.34%
2016-12.57%-1.11%14.09%3.73%14.74%-14.00%3.64%8.69%-11.56%-27.50%-2.65%-11.85%-37.43%
2015-13.30%25.03%-3.62%-4.80%-51.64%-26.53%5.56%16.08%-14.36%15.00%4.35%26.72%-43.62%
2014-3.26%3.28%-21.37%-5.24%-23.73%-3.17%42.28%15.68%-6.64%14.21%-10.84%-8.57%-21.36%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 90, ICAD is among the top 10% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ICAD is 9090
Overall Rank
The Sharpe Ratio Rank of ICAD is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of ICAD is 9292
Sortino Ratio Rank
The Omega Ratio Rank of ICAD is 9090
Omega Ratio Rank
The Calmar Ratio Rank of ICAD is 9090
Calmar Ratio Rank
The Martin Ratio Rank of ICAD is 9090
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for iCAD, Inc. (ICAD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

iCAD, Inc. Sharpe ratios as of May 18, 2025 (values are recalculated daily):

  • 1-Year: 1.24
  • 5-Year: -0.20
  • 10-Year: -0.03
  • All Time: -0.09

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of iCAD, Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History


iCAD, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the iCAD, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the iCAD, Inc. was 99.16%, occurring on May 16, 2023. The portfolio has not yet recovered.

The current iCAD, Inc. drawdown is 97.04%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.16%Apr 9, 19879074May 16, 2023
-39.13%Dec 8, 198631Jan 21, 198733Mar 10, 198764
-11.48%Mar 18, 19879Mar 30, 19874Apr 3, 198713

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of iCAD, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of iCAD, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 68.0% positive surprise.


-0.20-0.15-0.10-0.050.000.0520212022202320242025
-0.02
-0.06
Actual
Estimate

Valuation

The Valuation section provides an overview of how iCAD, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for ICAD compared to other companies in the Health Information Services industry. ICAD currently has a PEG ratio of -0.6. This PEG ratio is negative, which typically signals that the company's earnings are expected to decline. A negative PEG is not considered meaningful for valuation purposes.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ICAD relative to other companies in the Health Information Services industry. Currently, ICAD has a P/S ratio of 5.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ICAD in comparison with other companies in the Health Information Services industry. Currently, ICAD has a P/B value of 3.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items